| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/25/2006 | EP1619498A2 Method of screening remedy for heart disease and medicinal composition for treating heart disease |
| 01/25/2006 | EP1619260A2 Methods of identifying point mutations in a genome |
| 01/25/2006 | EP1619259A2 Sequencing method using magnifying tags |
| 01/25/2006 | EP1619258A1 Method of detecting or quantitatively determining mitochondrial dna 3243 variation, and kit therefor |
| 01/25/2006 | EP1619257A1 Method for the in vitro diagnosis of non-alcoholic steatohepatitis |
| 01/25/2006 | EP1619256A1 Microorganism staining agent and use thereof |
| 01/25/2006 | EP1619251A1 A mRNA splice variant of the doublecortin-like kinase gene and its use in cancer diagnosis and therapy |
| 01/25/2006 | EP1619249A1 Induction of exon skipping in eukaryotic cells |
| 01/25/2006 | EP1619246A1 RNA dependent RNA polymerases from coronavirus and their use in molecular biology and drug screening |
| 01/25/2006 | EP1618383A1 Membrane strip biosensor system for point-of-care testing |
| 01/25/2006 | EP1618377A2 Chromogenic substrate with a ph indicator dye |
| 01/25/2006 | EP1618373A2 Apparatus and method to measure platelet contractility |
| 01/25/2006 | EP1618367A2 Optical detector for enzyme activation |
| 01/25/2006 | EP1618218A2 Methods for prognosis and treatment of solid tumors |
| 01/25/2006 | EP1618217A2 Bcl2l12 polypeptide activators and inhibitors |
| 01/25/2006 | EP1618216A2 Fragmentation-based methods and systems for de novo sequencing |
| 01/25/2006 | EP1618215A2 Oligonucleotides comprising a molecular switch |
| 01/25/2006 | EP1618214A2 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification |
| 01/25/2006 | EP1618213A2 Fancc, dad1, grim19 and hadhii genes of psoriasis |
| 01/25/2006 | EP1618212A1 Mutations in the human pcsk9 gene associated to hypercholesterolemia |
| 01/25/2006 | EP1618211A1 Exciplexes |
| 01/25/2006 | EP1618210A1 Associations of polymorphisms in the frzb gene with obesity and osteoporosis |
| 01/25/2006 | EP1618209A2 High throughput functional genomic screening methods for osteoarthritis |
| 01/25/2006 | EP1618208A1 Plasminogen activator inhibitor-1 (pai-1) haplotypes useful as indicators of patient outcome |
| 01/25/2006 | EP1618207A2 Medical device for monitoring blood phenylalanine levels |
| 01/25/2006 | EP1618206A2 Apparatus and method for detecting live cells with an integrated filter and growth detection device |
| 01/25/2006 | EP1618205A2 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 01/25/2006 | EP1618203A2 Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade |
| 01/25/2006 | EP1618189A2 Rnai agents for anti-sars coronavirus therapy |
| 01/25/2006 | EP1618187A2 Multiply-primed amplification of nucleic acid sequences |
| 01/25/2006 | EP1618181A2 Polyvalent protein complex |
| 01/25/2006 | EP1618132A2 Composition and methods for the treatment of immune disorders |
| 01/25/2006 | EP1618131A2 Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof |
| 01/25/2006 | EP1618127A2 The severe acute respiratory syndrome coronavirus |
| 01/25/2006 | EP1618124A2 Prophylactic and therapeutic benefits of new class of immune stimulating peptides |
| 01/25/2006 | EP1618123A2 Peptide substrate libraries |
| 01/25/2006 | EP1617878A1 High throughput biological indicator reader technical filed |
| 01/25/2006 | EP1617858A2 Use of active ingredients for preventing or treating viral illnesses, and test system for discovering such active ingredients |
| 01/25/2006 | EP1617829A2 Yeast ectopically expressing abnormally processed proteins and uses therefor |
| 01/25/2006 | EP1617723A2 Bacteriophage for lysis of methylobacterium and compositions and uses thereof |
| 01/25/2006 | EP1494695A4 Plasma protein-binding ligands |
| 01/25/2006 | EP1490692B1 Diagnostic and therapeutic use of caps |
| 01/25/2006 | EP1474430B1 Bi-functionalised metallocenes use for marking biological molecules |
| 01/25/2006 | EP1461071A4 Muscle transcription factors |
| 01/25/2006 | EP1402065A4 Method for detecting transcription factor-protein interactions |
| 01/25/2006 | EP1337342B1 Microsystem for the dielectric and optical manipulation of particles |
| 01/25/2006 | EP1299730B1 Fourier transform mass spectrometry of complex biological samples |
| 01/25/2006 | EP1235068B1 Biosensor |
| 01/25/2006 | EP1212462B1 Methods of determining the presence of double stranded nucleic acids in a sample |
| 01/25/2006 | EP1198713B1 Detection and identification of bacterial strains |
| 01/25/2006 | EP1144650B1 Goodpasture antigen binding protein |
| 01/25/2006 | EP0980427B1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 01/25/2006 | CN1726432A Laser exposure of photosensitive masks for DNA microarray fabrication |
| 01/25/2006 | CN1726393A Compounds and methods for detection of carcinomas and their precursor lesions |
| 01/25/2006 | CN1726290A Method for generating a genetically modified organism for screening active substances |
| 01/25/2006 | CN1726289A Haplotype partitioning in the proximal promoter of the human growth hormone (GH1) gene |
| 01/25/2006 | CN1726288A Vessel, method and apparatus for dissolution testing of an annular pharmaceutical delivery device |
| 01/25/2006 | CN1726287A Method of distinguishing drug-resistance of hepatitis b virus |
| 01/25/2006 | CN1726286A Method and device for identifying germs |
| 01/25/2006 | CN1726277A Coenzyme-binding glucose dehydrogenase |
| 01/25/2006 | CN1726228A Monitor protein for measuring processing of protein |
| 01/25/2006 | CN1725006A Methods and compositions for characterizing a redox reagent system enzyme |
| 01/25/2006 | CN1724692A Reagent and method for detecting leucocythemia susceptibility |
| 01/25/2006 | CN1724691A Kjeldahl comprehensive syndrome fetal molecule dingnosis reagent box and application |
| 01/25/2006 | CN1724690A Detecting and parting method of chlamydia trachomatic PCR RLB and used primer, probe |
| 01/25/2006 | CN1724689A Strain specificity PCR detection method of heredity modified corn strain MON863 |
| 01/25/2006 | CN1724688A Complex aplification detecting system of fluorescent marker short tandem repetitive sequence gene locus |
| 01/25/2006 | CN1724687A Relativity of proangiotension transferase 2 gene and prinary hypertension |
| 01/25/2006 | CN1724686A Target sequence used for detecting mycoplasma pnoumoniae and reagent box |
| 01/25/2006 | CN1724681A Method of detecting tuberculosis mycobacillus complex and non tuberculosis mycobacillus and its reagent box |
| 01/25/2006 | CN1724669A Method in increasing oleic acid content of soybean and peanut seed by applying gene silent technology |
| 01/25/2006 | CN1724668A Paddy rice Osfad 8 coded sequence and its application |
| 01/25/2006 | CN1724665A Human new gene TRIKS and its coded protein |
| 01/25/2006 | CN1238721C Sample analyzing method |
| 01/25/2006 | CN1238711C Biosensor and investigating device for biosensor |
| 01/25/2006 | CN1238526C Layered type technique for preparing biochip in micro array mode |
| 01/25/2006 | CN1238525C Preparation method of biochip in micro array |
| 01/25/2006 | CN1238524C PCR method for authenticating Anoplophora glabripenis |
| 01/25/2006 | CN1238523C Method for sieving constituents capable of reducing cholesterin in blood fat through gene target |
| 01/25/2006 | CN1238522C Interleukin-2 and test method of its gene in drug-stopping application |
| 01/25/2006 | CN1238521C Uses of A section of man-type mycoplasma DNA sequence (4) |
| 01/25/2006 | CN1238520C Crystal structure of cPLAz and methods of identifying agonists and antagonists using same |
| 01/25/2006 | CN1238504C Tumour related gene and use thereof |
| 01/25/2006 | CN1238375C Chlorine-ion/ bicarbonate radical exchange protein drived by sodium-ion |
| 01/25/2006 | CN1238369C Pure honeysuckle polymerase chain reaction-restriction map identification method |
| 01/25/2006 | CN1238367C Isolated nucleic acid molecules which encode T cell inducible factors (TIF), proteins encoded, and uses thereof |
| 01/25/2006 | CN1238366C Selection of proteins using RNA-protein fusions |
| 01/24/2006 | US6989897 Metal coated nanocrystalline silicon as an active surface enhanced Raman spectroscopy (SERS) substrate |
| 01/24/2006 | US6989472 cDNA sequence transcribing an mRNA encoding the terminal oxidase associated with carotenoid biosynthesis, and uses thereof |
| 01/24/2006 | US6989442 Synthesizing nucleic acid, contacting with a alkylamine, loading mixture onto media and applying a purification gradient using a suitable elution buffer |
| 01/24/2006 | US6989436 Stabilization of cardiac troponin I subunits and complexes |
| 01/24/2006 | US6989400 Treatment of benign prostatic hyperplasia |
| 01/24/2006 | US6989270 Using polyamide nucleic acid oligomers to engender a biological response |
| 01/24/2006 | US6989269 Cells for drug discovery |
| 01/24/2006 | US6989262 Plasmin variants and uses thereof |
| 01/24/2006 | US6989261 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 01/24/2006 | US6989260 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 01/24/2006 | US6989259 Recombinant methods for making reverse transcriptases and mutants thereof |
| 01/24/2006 | US6989256 Identifying regulators of translational efficiency which compete with modulator of translation termination (MTT1) for use in treatment and prevention of blood, nervous system, tumor, muscular, respiratory and kidney disorders |
| 01/24/2006 | US6989255 for protection against staphylococcus infection; fusion proteins |